China SXT Pharmaceuticals vs 60 Degrees Pharmaceuticals
SXTC and SXTP side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SXTC and SXTP compare
60 Degrees Pharmaceuticals grew revenue faster over the last twelve months (73.2% versus −34.6% for China SXT Pharmaceuticals).
China SXT Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −545% compared with −730% at 60 Degrees Pharmaceuticals.
60 Degrees Pharmaceuticals scores higher on the StockData Score (8 against 4 for China SXT Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SXTC | SXTP |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.8M |
| Share price | $3.00 | $0.518 |
| Change, 1 year | −100.0% | −89.5% |
| Change, 5 years | −100% | – |
| Beta (5Y) | – | 2.09 |
| Employees | 56 | 3 |
| StockData Score | ||
| Total score | 4 | 8 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 1 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 1.6× |
| P/B | – | 0.7× |
| FCF yield | – | −488% |
| Fair value | – | $1.29 |
| Margin of safety | – | 59.7% |
| Growth | ||
| Revenue growth (TTM) | −34.6% | 73.2% (better) |
| Revenue growth, 5Y average | −24.9% | – |
| Profitability | ||
| Gross margin | 21.9% (better) | 19.4% |
| Operating margin | −626% (better) | −775% |
| Net margin | −545% (better) | −730% |
| FCF margin | – | −801% |
| Return on equity | −27.5% (better) | −322% |
| Return on invested capital | −1657% | −659% (better) |
| Financial health | ||
| Debt / equity | 0.03 | 0.00 (better) |
| Interest coverage | −113.1× (better) | −1134.8× |
| Current ratio | 7.93 (better) | 2.32 |
| Altman Z-score | – | −22.23 |
| Piotroski F-score | 3 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 21.5% |
| Held by insiders | 0.00% | 21.0% |
| Insider net buying, 12 months | – | $30.1K |
| Short interest, % of float | 2.9% | – |
Go deeper
- SXTC stock overview
- SXTC income statement
- SXTC valuation and score
- SXTP stock overview
- SXTP income statement
- SXTP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.